Klotho protein in neurodegenerative disorders
نویسندگان
چکیده
منابع مشابه
hdac inhibitors in neurodegenerative disorders
neurodegenerative disorders such as huntingtons disease, alzheimers disease, parkinsons disease, amyotrophic lateral sclerosis, spinal muscular atrophy, friedreichs ataxia, and others are multi-factorial illnesses in which many pathways (still poorly understood) act serially and in parallel to give a determined pathologic phenotype. thus, presently there are no effective cures for these disease...
متن کاملNeuroregeneration in neurodegenerative disorders
BACKGROUND Neuroregeneration is a relatively recent concept that includes neurogenesis, neuroplasticity, and neurorestoration--implantation of viable cells as a therapeutical approach. DISCUSSION Neurogenesis and neuroplasticity are impaired in brains of patients suffering from Alzheimer's Disease or Parkinson's Disease and correlate with low endogenous protection, as a result of a diminished...
متن کاملTransglutaminases in neurodegenerative disorders.
Type 2 transglutaminase (TG2) is a calcium-dependent acyltransferase which also undergoes a GTP-binding/GTPase cycle even though it lacks any obvious sequence similarity with canonical GTP-binding (G) proteins. As an enzyme which is responsible for the majority of transglutaminase (TG) activity in the brain, TG2 is likely to play a modulatory role in nervous system development and has regulator...
متن کاملKlotho as a Novel Cardioprotective Protein in Aged Heart
In recent years, researchers have been looking for genes whose products can directly affect the aging process. Among these, the anti-aging protein klotho has attracted much attention. This single transmembrane protein is expressed in the renal tissues, parathyroid gland and choroid network of the brain and acts as a co-receptor for Fibroblast Growth Factor FGF. In this way, it contributes to c...
متن کاملSearching for Common Protein Networks in Neurodegenerative Disorders
Neurodegenerative disorders (NDDs) consist of several distinct categories of diseases and each manifests its own unique symptoms. However, the diseases share several common features, especially aggregation and deposition of abnormal proteins [1, 3]. The objective of our research is to understand any common molecular pathogenic mechanisms in the sense of protein-protein interaction network by in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurological Sciences
سال: 2018
ISSN: 1590-1874,1590-3478
DOI: 10.1007/s10072-018-3496-x